140 related articles for article (PubMed ID: 33042341)
61. Phyllodes tumors of the breast diagnostic and therapeutic dilemmas.
Fajdić J; Gotovac N; Hrgović Z; Kristek J; Horvat V; Kaufmann M
Onkologie; 2007 Mar; 30(3):113-8. PubMed ID: 17341897
[TBL] [Abstract][Full Text] [Related]
62. A giant phyllodes tumor of the breast causing severe disfigurement. A case report.
Franceschini G; Di Giorgio D; D'Archi S; Di Leone A; Sanchez AM; Masetti R
Ann Ital Chir; 2017 Jan; 6():. PubMed ID: 28406095
[TBL] [Abstract][Full Text] [Related]
63. Transformation of a Benign-Appearing Fibroepithelial Lesion to a Giant Malignant Phyllodes Tumor of the Breast.
Paxton EG; Mabry H; Alattia L
Cureus; 2022 Dec; 14(12):e32881. PubMed ID: 36699789
[TBL] [Abstract][Full Text] [Related]
64. Malignant Phyllodes Tumor of the Breast and Pregnancy: A Rare Case Report and Literature Review.
Mustață L; Gică N; Botezatu R; Chirculescu R; Gică C; Peltecu G; Panaitescu AM
Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056344
[TBL] [Abstract][Full Text] [Related]
65. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast.
Feakins RM; Wells CA; Young KA; Sheaff MT
Hum Pathol; 2000 Oct; 31(10):1214-22. PubMed ID: 11070114
[TBL] [Abstract][Full Text] [Related]
66. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
[TBL] [Abstract][Full Text] [Related]
67. Increased c-kit (CD117) expression in malignant mammary phyllodes tumors.
Tse GM; Putti TC; Lui PC; Lo AW; Scolyer RA; Law BK; Karim R; Lee CS
Mod Pathol; 2004 Jul; 17(7):827-31. PubMed ID: 15044924
[TBL] [Abstract][Full Text] [Related]
68. Phyllodes Tumor of the Breast: Ultrasound-Pathology Correlation.
Kalambo M; Adrada BE; Adeyefa MM; Krishnamurthy S; Hess K; Carkaci S; Whitman GJ
AJR Am J Roentgenol; 2018 Apr; 210(4):W173-W179. PubMed ID: 29412020
[TBL] [Abstract][Full Text] [Related]
69. A retrospective review of phyllodes tumors of the breast from a single institution.
Yuniandini A; Hamdani W; Prihantono P; Faruk M
Breast Dis; 2021; 40(S1):S63-S70. PubMed ID: 34092583
[TBL] [Abstract][Full Text] [Related]
70. Immunohistochemical expression of Ki-67, p53, and CD10 in phyllodes tumor and their correlation with its histological grade.
Shubham S; Ahuja A; Bhardwaj M
J Lab Physicians; 2019; 11(4):330-334. PubMed ID: 31929699
[TBL] [Abstract][Full Text] [Related]
71. Benign phyllodes tumours of the breast: (Over) treatment of margins - A literature review.
Shaaban M; Barthelmes L
Eur J Surg Oncol; 2017 Jul; 43(7):1186-1190. PubMed ID: 27939569
[TBL] [Abstract][Full Text] [Related]
72. Aggressive malignant phyllodes tumor.
Roberts N; Runk DM
Int J Surg Case Rep; 2015; 8C():161-5. PubMed ID: 25697402
[TBL] [Abstract][Full Text] [Related]
73. Phyllodes tumours - a retrospective review of 83 clinical cases.
Mužlayová P; Coufal O; Fabian P; Svobodník A; Zapletal O
Rozhl Chir; 2019; 98(9):362-369. PubMed ID: 31698912
[TBL] [Abstract][Full Text] [Related]
74. The phyllodes menace-Variation in course, therapy, and appearance of phyllodes tumors in a case series of three patients.
Schiltz D; Sokolow AJ; Minck N; Schreml S; Moser L; von Fritschen U
Clin Case Rep; 2023 Sep; 11(9):e7836. PubMed ID: 37663819
[TBL] [Abstract][Full Text] [Related]
75. Extramammary Borderline Phyllodes Tumor Presenting as an Umbilical Mass.
Jackson J; Walker E; Bethune R; Bracey T; Mason C; Mandalia T
Int J Surg Pathol; 2021 Sep; 29(6):648-652. PubMed ID: 33345669
[TBL] [Abstract][Full Text] [Related]
76. Expression of lymphoid enhancer-binding factor 1 in breast fibroepithelial lesions.
Chen PH; Bossuyt V; Reisenbichler E
Hum Pathol; 2021 Feb; 108():68-75. PubMed ID: 33245988
[TBL] [Abstract][Full Text] [Related]
77. Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists.
Sars C; Sackey H; Frisell J; Dickman PW; Karlsson F; Kindts I; Marta GN; Freitas-Junior R; Tvedskov TF; Kassem L; Ali AS; Ihalainen H; Neron M; Kontos M; Kaidar-Person O; Meattini I; Francken AB; van Duijnhoven F; Moberg IO; Marinko T; Kollar A; Ahmed M; Remoundos D; Banks J; Jagsi R; Dossett LA; Lindqvist EK
Breast Cancer Res Treat; 2023 Jun; 199(2):293-304. PubMed ID: 36879102
[TBL] [Abstract][Full Text] [Related]
78. How to approach phyllodes tumors of the breast?
Acar T; Tarcan E; Hacıyanlı M; Kamer E; Peşkersoy M; Yiğit S; Gür Ö; Cin N; Sarı AA; Tatar F
Ulus Cerrahi Derg; 2015; 31(4):197-201. PubMed ID: 26668526
[TBL] [Abstract][Full Text] [Related]
79. Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases.
Niezabitowski A; Lackowska B; Rys J; Kruczak A; Kowalska T; Mitus J; Reinfuss M; Markiewicz D
Breast Cancer Res Treat; 2001 Jan; 65(1):77-85. PubMed ID: 11245343
[TBL] [Abstract][Full Text] [Related]
80. Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast.
Abdalla HM; Sakr MA
J Egypt Natl Canc Inst; 2006 Jun; 18(2):125-33. PubMed ID: 17496937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
